Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 1c, Sales Fall Inline
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $125.16 +0.09%
Revenue Growth %: +4.4%
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +4.4%
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q3 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.11 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
- Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald: Yeztugo Total TRx Down
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
